X-154835925-C-T
Position:
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_000132.4(F8):c.*1672G>A variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.567 in 110,970 control chromosomes in the GnomAD database, including 14,753 homozygotes. There are 19,046 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.57 ( 14753 hom., 19046 hem., cov: 23)
Exomes 𝑓: 0.50 ( 0 hom. 0 hem. )
Consequence
F8
NM_000132.4 3_prime_UTR
NM_000132.4 3_prime_UTR
Scores
2
Clinical Significance
Conservation
PhyloP100: 1.33
Genes affected
F8 (HGNC:3546): (coagulation factor VIII) This gene encodes coagulation factor VIII, which participates in the intrinsic pathway of blood coagulation; factor VIII is a cofactor for factor IXa which, in the presence of Ca+2 and phospholipids, converts factor X to the activated form Xa. This gene produces two alternatively spliced transcripts. Transcript variant 1 encodes a large glycoprotein, isoform a, which circulates in plasma and associates with von Willebrand factor in a noncovalent complex. This protein undergoes multiple cleavage events. Transcript variant 2 encodes a putative small protein, isoform b, which consists primarily of the phospholipid binding domain of factor VIIIc. This binding domain is essential for coagulant activity. Defects in this gene results in hemophilia A, a common recessive X-linked coagulation disorder. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.92).
BP6
Variant X-154835925-C-T is Benign according to our data. Variant chrX-154835925-C-T is described in ClinVar as [Benign]. Clinvar id is 368105.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chrX-154835925-C-T is described in Lovd as [Benign].
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.772 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
F8 | NM_000132.4 | c.*1672G>A | 3_prime_UTR_variant | 26/26 | ENST00000360256.9 | NP_000123.1 | ||
F8 | NM_019863.3 | c.*1672G>A | 3_prime_UTR_variant | 5/5 | NP_063916.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
F8 | ENST00000360256.9 | c.*1672G>A | 3_prime_UTR_variant | 26/26 | 1 | NM_000132.4 | ENSP00000353393 | P1 | ||
F8 | ENST00000330287.10 | c.*1672G>A | 3_prime_UTR_variant | 5/5 | 1 | ENSP00000327895 |
Frequencies
GnomAD3 genomes AF: 0.567 AC: 62888AN: 110916Hom.: 14756 Cov.: 23 AF XY: 0.574 AC XY: 19032AN XY: 33180
GnomAD3 genomes
AF:
AC:
62888
AN:
110916
Hom.:
Cov.:
23
AF XY:
AC XY:
19032
AN XY:
33180
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.500 AC: 1AN: 2Hom.: 0 Cov.: 0AC XY: 0AN XY: 0
GnomAD4 exome
AF:
AC:
1
AN:
2
Hom.:
Cov.:
0
AC XY:
0
AN XY:
0
Gnomad4 FIN exome
AF:
GnomAD4 genome AF: 0.567 AC: 62893AN: 110968Hom.: 14753 Cov.: 23 AF XY: 0.573 AC XY: 19046AN XY: 33242
GnomAD4 genome
AF:
AC:
62893
AN:
110968
Hom.:
Cov.:
23
AF XY:
AC XY:
19046
AN XY:
33242
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:1
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Hereditary factor VIII deficiency disease Benign:1
Benign, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Jan 12, 2018 | This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at